Suppr超能文献

智利塔尔卡市成年人代谢综合征的评估

Evaluation of metabolic syndrome in adults of Talca city, Chile.

作者信息

Mujica Veronica, Leiva Elba, Icaza Gloria, Diaz Nora, Arredondo Miguel, Moore-Carrasco Rodrigo, Orrego Roxana, Vásquez Marcela, Palomo Ivan

机构信息

Diabetes and Cardiovascular Program, Maule Health Service, Talca, Chile.

出版信息

Nutr J. 2008 May 15;7:14. doi: 10.1186/1475-2891-7-14.

Abstract

OBJECTIVE

Insulin resistance (IR) is an important risk factor for type 2 Diabetes Mellitus (DM2) and cardiovascular disease (CVD). Metabolic Syndrome (MS) is a clustering of metabolic alterations associated to IR; however, there is no international consensus for defining its diagnosis. Our objective was to evaluate the prevalence and characteristics of MS identified by the ATP III and IDF criteria in adults from Talca city.

RESEARCH AND METHODS

We studied 1007 individuals, aged 18-74, and residents from Talca. MS subjects were defined according to ATP III (three altered factors) and IDF criteria (patients with waist circumference >80/90 cm (W/M) and two others altered factors).

RESULTS

The prevalence of metabolic syndrome according to the IDF and ATP III criteria was 36.4% and 29.5%, respectively after adjustment for age and sex. The agreement for both criteria was 89%. The prevalence in men was higher than in women for both MS definitions, although not significant. MS probability increased with age, and the highest risk was in the 57-68 age group (ATP-MS) and 53-72 age group (IDF-MS). Hypertension, high triglycerides and abdominal obesity are the most frequent alterations in MS.

CONCLUSION

MS prevalence in adults was higher when diagnosed with IDF than with ATP criterion; in both, age is directly related with the MS presence. The MS subjects showed higher levels of blood pressure, waist circumference and plasma triglycerides. Considering our results, it is worrisome that one third of our population has a high risk of developing DM2 and CVD in the future.

摘要

目的

胰岛素抵抗(IR)是2型糖尿病(DM2)和心血管疾病(CVD)的重要危险因素。代谢综合征(MS)是与IR相关的一组代谢改变;然而,对于其诊断的定义尚无国际共识。我们的目的是评估按照ATP III和IDF标准确定的MS在塔尔卡市成年人中的患病率及特征。

研究与方法

我们研究了1007名年龄在18 - 74岁之间、居住在塔尔卡的居民。MS受试者根据ATP III(三项改变因素)和IDF标准(腰围>80/90 cm(女性/男性)且另有两项改变因素的患者)来定义。

结果

在对年龄和性别进行调整后,根据IDF和ATP III标准,代谢综合征的患病率分别为36.4%和29.5%。两种标准的一致性为89%。对于两种MS定义,男性的患病率均高于女性,尽管差异不显著。MS的患病概率随年龄增加,最高风险出现在57 - 68岁年龄组(ATP - MS)和53 - 72岁年龄组(IDF - MS)。高血压、高甘油三酯和腹部肥胖是MS中最常见的改变。

结论

按照IDF标准诊断时,成年人中MS的患病率高于ATP标准;在这两种标准下,年龄均与MS的存在直接相关。MS受试者的血压、腰围和血浆甘油三酯水平较高。考虑到我们的研究结果,令人担忧的是我们三分之一的人口未来有患DM2和CVD的高风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ad6/2397433/66105a7b2bf9/1475-2891-7-14-1.jpg

相似文献

1
Evaluation of metabolic syndrome in adults of Talca city, Chile.
Nutr J. 2008 May 15;7:14. doi: 10.1186/1475-2891-7-14.
2
Discordance of metabolic syndrome and abdominal obesity prevalence according to different criteria in Andean highlanders: A community-based study.
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S359-S364. doi: 10.1016/j.dsx.2017.03.016. Epub 2017 Mar 6.
3
Comparative analysis of IDF, ATPIII and CDS in the diagnosis of metabolic syndrome among adult inhabitants in Jiangxi Province, China.
PLoS One. 2017 Dec 7;12(12):e0189046. doi: 10.1371/journal.pone.0189046. eCollection 2017.
4
[Prevalence of metabolic syndrome using NCEP-ATPIII and IDF definitions in Brazilian individuals].
Rev Assoc Med Bras (1992). 2007 Sep-Oct;53(5):407-13. doi: 10.1590/s0104-42302007000500016.
6
[Prevalence of metabolic syndrome among Chilean adults].
Rev Med Chil. 2010 Jun;138(6):707-14. doi: 10.4067/s0034-98872010000600007.
10
The lipid accumulation product is a powerful tool to predict metabolic syndrome in undiagnosed Brazilian adults.
Clin Nutr. 2017 Dec;36(6):1693-1700. doi: 10.1016/j.clnu.2016.12.020. Epub 2016 Dec 28.

引用本文的文献

2
Prevalence of Obesity and Metabolic Syndrome in the High Cardiovascular Risk Setting of Rural Western Honduras.
Ethn Dis. 2024 Apr 10;33(2-3):124-129. doi: 10.18865/ed.33.2-3.124. eCollection 2023 Apr.
3
Using A Body Shape Index (ABSI) and Body Roundness Index (BRI) to predict risk of metabolic syndrome in Peruvian adults.
J Int Med Res. 2020 Jan;48(1):300060519848854. doi: 10.1177/0300060519848854. Epub 2019 May 30.
4
Prevalence of Metabolic Syndrome and Affecting Factors among Individuals Aged 30 and over in Balçova District of İzmir.
Balkan Med J. 2016 May;33(3):331-8. doi: 10.5152/balkanmedj.2016.141033. Epub 2016 May 1.
5
Prevalence of metabolic syndrome in the Brazilian Xavante indigenous population.
Diabetol Metab Syndr. 2015 Nov 21;7:105. doi: 10.1186/s13098-015-0100-x. eCollection 2015.
6
Serum Ferritin Is Associated with Metabolic Syndrome and Red Meat Consumption.
Oxid Med Cell Longev. 2015;2015:769739. doi: 10.1155/2015/769739. Epub 2015 Sep 14.
7
Subjects with impaired fasting glucose: evolution in a period of 6 years.
J Diabetes Res. 2014;2014:710370. doi: 10.1155/2014/710370. Epub 2014 Aug 20.
8
Prevalence of metabolic syndrome in Brazilian adults: a systematic review.
BMC Public Health. 2013 Dec 18;13:1198. doi: 10.1186/1471-2458-13-1198.
9
Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome.
Mediators Inflamm. 2013;2013:136584. doi: 10.1155/2013/136584. Epub 2013 Jun 13.
10
The metabolic syndrome: a modern plague spread by modern technology.
J Clin Hypertens (Greenwich). 2009 Dec;11(12):755-60. doi: 10.1111/j.1751-7176.2009.00191.x.

本文引用的文献

1
[Prevalence of cardiovascular risk factors in adult from Talca, Chile].
Rev Med Chil. 2007 Jul;135(7):904-12. doi: 10.4067/s0034-98872007000700011. Epub 2007 Sep 6.
4
Abdominal obesity and metabolic syndrome.
Nature. 2006 Dec 14;444(7121):881-7. doi: 10.1038/nature05488.
5
Metabolic syndrome in young adults from two socioeconomic Latin American settings.
Nutr Metab Cardiovasc Dis. 2007 Oct;17(8):581-9. doi: 10.1016/j.numecd.2006.06.001. Epub 2006 Aug 8.
6
Point: impaired fasting glucose: The case for the new American Diabetes Association criterion.
Diabetes Care. 2006 May;29(5):1170-2. doi: 10.2337/diacare.2951170.
9
Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin resistance.
Diabetes Care. 2006 Mar;29(3):668-72. doi: 10.2337/diacare.29.03.06.dc05-0970.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验